REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Genexine Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services
Full name: Genexine Inc. Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Genexine Inc. is engaged in research and development of biotechnology. The company offers innovative immunotherapeutics and next generation novel long acting biologics.Genexine Inc technologies offers HYFC platform which produces long acting Fc fusion proteins by hybriding lgD and lgG4; and Immunotherapy which includes Therapeutic DNA Vaccine Technology as well as Immune Enchancing Technology. Genexine Inc. focuses on three key therapeutics areas: orphans, cancers and immune disorders. The company was formerly known as Genexine Co., Ltd.Genexine Inc. was incorporated in 1999 and is based Seongnam ,South Korea.

Headquarters
4F, B Dong, Korea Bio Park, 700, Daewangpangyo-Ro, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi;

Contact Details: Purchase the Genexine Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Genexine Inc. report to view the information.
Outstanding Shares:
Purchase the Genexine Inc. report to view the information.
Registered Capital:
Purchase the Genexine Inc. report to view the information.
Financial Auditors:
Purchase the Genexine Inc. report to view the information.
Incorporation Date:
June 08, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
16.57%
Purchase this report to view the information.
1.58%
Purchase this report to view the information.
0.64%
Purchase this report to view the information.
0.59%
Purchase this report to view the information.
0.48%
Subsidiaries
Ilkogen
50%
Simnogen
49%
Kg-Bio
40%
Company Performance
Financial values in the chart are available after Genexine Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-79.09%▼
Total operating revenue
-99.25%▼
Operating profit (EBIT)
-46.89%▼
EBITDA
-45.94%▼
Net Profit (Loss) for the Period
-283.03%▼
Total assets
-11.61%▼
Total equity
-12.48%▼
Operating Profit Margin (ROS)
-2178.09%▼
Net Profit Margin
-2269.42%▼
Return on Equity (ROE)
-18.11%▼
Debt to Equity Ratio
4.33%▲
Quick Ratio
0.26%▲
Cash Ratio
-0.59%▼

Similar companies

Chong Kun Dang Pharmaceutical Corp.
 
SK Chemicals Co.Ltd
Daewoong Co.,Ltd.
 
Yuhan Corporation
Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo